Mattermark Daily – Monday, February 9th, 2015
From the Investors Bruce Booth of Atlas Venture provides his thoughts on the ‘therapeutic-directed venture capital’ investments from Biotechnology Industry Organization’s VC study in “Where Does All That Biotech Venture… Read Full Article